Navigating the Frontier of Hematologic Malignancy Therapies (1 of 5 Modules)
This activity provides an overview of data for new and emerging T-cell directed bispecific antibodies in the management of hematologic malignancies, with a focus on multiple myeloma.
Upon completion of this activity, participants should be better able to:
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources